Predicts overall and progression-free survival in DLBCL based on risk factors. ... Note: IPI results are included for historical comparisons only. Use in CD20+ ...Thisisanunprecedentedtime.Itisthededicationofhealthcareworkersthatwillleadusthroughthiscrisis.Thankyouforeverythingyoudo.COVID-19ResourceCenterCalcFunctionCalcsthathelppredictprobabilityofadiseaseDiagnosisSubcategoryof'Diagnosis'designedtobeverysensitiveRuleOutDiseaseisdiagnosed:prognosticatetoguidetreatmentPrognosisNumericalinputsandoutputsFormulaMedtreatmentandmoreTreatmentSuggestedprotocolsAlgorithmDiseaseSelect...SpecialtySelect...ChiefComplaintSelect...OrganSystemSelect...PatentPendingLogInEmailAddressPasswordShowForgotyourpassword?LogInOrcreateanewaccount(it'sfree)ForgotPassword?EmailAddressEnteryouremailaddressandwe'llsendyoualinktoresetyourpassword.GetNewPasswordSignInRequiredTosavefavorites,youmustlogin.Creatinganaccountisfree,easy,andtakesabout60seconds.LogInCreateAccountAttentionCOACHSTUDYparticipants:Theprincipalinvestigatorsofthestudyrequestthatyouusetheofficialversionofthemodifiedscorehere.InternationalPrognosticIndexforDiffuseLargeB-cellLymphoma(IPIandR-IPI)Predictsoverallandprogression-freesurvivalinDLBCLbasedonriskfactors.INSTRUCTIONSNote:IPIresultsareincludedforhistoricalcomparisonsonly.UseinCD20+DLBCLpatients.DonotuseinpatientswithHIV,secondarymalignancies,lowgradelymphoproliferativedisorders,orcomorbiditiesprecludingcurativetherapyattempt.WhentoUsePearls/PitfallsWhyUseUseinCD20+DLBCLpatients.DonotuseinpatientswithHIV,secondarymalignancies,lowgradelymphoproliferativedisorders,orcomorbiditiesprecludingcurativetherapyattempt.TheInternationalPrognosticIndexforDiffuseLargeB-cellLymphoma(IPIandR-IPI)estimates4-yearprogression-freesurvivaland4-yearoverallsurvivalforpatientswithdiffuselargeB-cellnon-Hodgkin’slymphoma(DLBCL).TheR-IPIprovidesgreaterdiscriminationamongstDLBCLpatientswithdifferingsurvivalbasedoneasilyobtainedfactors.Doesnotidentifyanyriskgroupwith4-yearsurvival<50%;hence,othermolec